Atherosclerosis Elsevier Publishing
MODIFICATION SCLEROSIS
Company,
Amsterdam
OF ENZYME
IN THE
41
- Printed in The Netherlands
ACTIVITIES
IN EXPERIMENTAL
ATHERO-
RABBIT
J. PATELSKI*, D. E. BOWYER, G. A. GRESHAM
A. N. HOWARD,
I. W. JENNINGS,
C. J. R. THORNE
AND
Departments of Pathology, Cambridge (Great Britain) (Revised,
Investigative
Medicine
and Biochemistry,
University
of Cambridge,
received January 29th. 1970)
SUMMARY
In rabbits fed an atherogenic semi-synthetic diet, the following were found: in the aortic wall, decreased cholesterol esterase and increased lipase and phospholipase A activities, no changes in malate and lactate dehydrogenase activities, enhanced incorporation of free fatty acid into cholesterol esters, and increased accumulation of mainly esterified and also free cholesterol; increase in plasma cholesterol and serum phospholipase A activity but no change in liver phospholipase A and serum and liver lipase activities. Compared with control animals, those fed the same diet and injected with Lipostabil
(a drug containing
polyunsaturated
lecithin)
showed no alterations
in the
aortic enzyme activities and serum phospholipase A and in the incorporation of free fatty acid into aortic cholesterol esters; serum and liver lipase activities were increased. Compared with atherogenic diet-fed animals injected with saline, the severity of atherosclerosis and the incorporation of free fatty acids into the aortic wall were reduced; there was no change in the elevated plasma cholesterol levels. The mechanism of cholesterol ester accumulation in the arterial
wall is dis-
cussed in the light of these observations.
Key words:
Cholesterol
esters - Lipolytic
enzymes
- Lipostabil
- Rabbit
atherosclerosis
INTRODUCTION
The cholesterol * Permanent (Poland).
relationship between the metabolism of phospholipids, glycerides esters in the arterial wall and the development of atherosclerosis address:
Department
of
Physiological
Chemistry,
Medical
Academy,
Atherosclerosis,
and has Poznan
1970, 12: 41-53
42
J. PATELSKI et al.
become a subject of considerable interest in recent years. In vitro studies on the biochemistry of enzymes involved in metabolism of these fatty acid esters have been performedr, but not much is known about the factors affecting the enzyme activities irz viva. In a previous study, it was shown that in experimental atherosclerosis in rats and in rabbits, there is an increase in lipase* and a decrease in cholesterol esterase activity in the arterial wall. It was suggested that these might be contributing factors in the production of the arterial lesionss. The present experiments were carried out in order to test whether the activities of the arterial enzymes involved in fatty acid ester metabolism could be modified and how this might affect the arterial
wall. Measurements
were made in rabbits
fed
control and atherogenic diets and injected with a drug containing polyunsaturated lecithin, of the following: (1) the specific activities of phospholipase A, lipase and cholesterol esterase, and lactate and malate dehydrogenases in aortic, liver and serum extracts, (2) [ I-r%]oleic acid incorporation into aortic lipids, (3) concentration of aortic phospholipids, free and esterified cholesterol, and free fatty acids. The aortas were also examined macroscopically
and microscopically.
MATERIALS AND METHODS
Reagents and substrates Commercial reagents of reagent grade were used and organic solvents were redistilled before use. The purity of substrates liquid chromatographys.
was checked by thin-layer and gas-
The substrates were prepared as hydrosolsl as follows: both
glyceryl trioleate (Calbiochem, U.S.) and cholesteryl
oleate (Koch-Light,
England)
were dissolved in boiling absolute ethanol (50 pmoles/5 ml). 5 ml of solution was then added to 15 ml of water (for glyceryl trioleate) or 15 ml of 2.135% (w/v) sodium taurocholate
solution (Calbiochem) (for cholesteryl oleate) in 25 ml glass vessels, at
approximately 80°C and the mixture sonicated for 20 min (MSE Ultrasonic disintegrator, output 60 W, Measuring and Scientific Equipment LTD, England, for 5 min). These hydrosols were kept at room temperature.
Lecithin
(from egg yolk,
Koch-Light), and polyunsatureated lecithin (EPL, Nattermann) were prepared by sonicating the phospholipid in distilled water and stored at 4°C. Total4 and frees fatty acid concentrations were measured in the hydrosols. Lipostabil (Nattermann, Cologne, Germany) was an intravenous injection of EPL commercial product did not contain nicotine acid or AMP.
(mg/ml) but unlike the
Alzimals Male New Zealand White rabbits, which were 24 weeks of age at the start of the experiment, were used. Control animals were fed a laboratory stock diet of commercial * Lipase-glycerol-ester hydrolase (EC 3.1.1.3)) phospholipase A-phosphatide-acyl hydrolase (EC 3.1.1.4), cholesterol esterase-sterol-ester hydrolase (EC 3.1.1.13)) malate dehydrogenase-Lmalate:NAD oxidoreductase (EC 1.1.1.37), lactate dehydrogenase-L-1actate:NAD oxidoreductase (EC 1.1.1.27). Atherosclerosis,
1970, 12: 41-53
MODIFiCATION
pellets.
OF ENZYME
ACTIVITIES
The experimental
animals
IN EXPERIMENTAL
43
ATHEROSCLEROSIS
were all fed a semi-synthetic
diet which produced
hyperlipaemia and atherosclerosis6. They were injected every 2nd day via the marginal ear vein as follows: Group A: 1.0 ml saline for 10 weeks, Group B: 1.0 ml Lipostabil for 10 weeks, Group C: 0.5 ml saline for 18 weeks, Group D: 0.5 ml Lipostabil
for 18
weeks. Preparation
of enzyme
extracts
After 24 h fasting,
the animals
drawn from the inferior
were killed by asphyxiation
vena cava. Samples
and frozen in solid COz. The abdominal
of liver were taken
aortas were prepared
with COz and blood (approximately
for perfusion
0.5 g)
and estima-
tion of lipid concentrations, as described below. The thoracic aortas were removed, the adventitia and loose connective tissue carefully stripped off, the aortas opened and divided
longitudinally
into two equal parts.
used for gross staining
and for microscopical
with
water,
ice-cold
Frozen
distilled
aortas
lyophilised
dried
with
blotting
and frozen livers were pulverised
for 48 h. Acetone-butanol
One part was put into formalin
examination.
and
The other part was rinsed
paper
and
frozen
in solid COz.
in a freeze press and the sera were
powders were then prepared
at -20°C
accord-
ing to MORTON~. For the assay of the activity of aortic enzymes, the powders were extracted with 50 o/0 (v/v) glycerol in water (7.515 mg/ml) for 30 min at 4°C using a Dacie
electric
cell suspension
mixer
(Surgical
and Scientific
Apparatus,
Matburn,
England). The extracts were decanted and filtered through Whatman No. 1 paper. The solid residue was re-extracted twice in half the original volume of glycerol-water by homogenising
in an Ultra-Turrax
(Janke and Kunkel)
for 5 sec. The second extracts
were filtered and mixed with the first. Liver and serum powders were extracted water (20 mg/ml) for 30 min at 4°C using the cell suspension determined according to Lowry et al. as described by LEGGETT Assay
of enzyme The
Protein
with was
BAILEY~.
activities
lijolytic
enzymes.
earlier’.
The reaction
distilled
water as follows:
(ii) Glyceryl
mixer.
trioleate
mixtures
The assay contained
was carried
out by the method
1 mM concentrations
(i) Egg yolk lecithin
or polyunsaturated
at pH 8.3 for the aortic enzyme,
of substrates lecithin
described in glass at pH 8.0.
pH 8.4 for the liver enzyme and
pH 8.9 for the serum enzyme and reduced glutathione (0.1 mAI). (iii) Cholesteryl oleate at pH 8.6 and reduced glutathione (0.1 mM) and sodium taurocholate (4 mm). Reactions were carried out by continuous titration in a pH-stat (Radiometer, Copenhagen) at 30°C under nitrogen, using 0.002 N KOH solution as the titrating reagent. The pH of the reaction mixture was adjusted to the appropriate value in the pH-stat and the enzyme extract (0.03-0.06 mg protein in 0.2-0.4 ml of aortic extract, 0.200.40 ml of protein in 0.05-O. 1 ml of liver extract and 0.50-1.00 mg of protein in 0.050.10 ml of serum extract) was added to give a total reaction mixture of 1 ml. Enzyme activity was measured by calculating the rate of release of fatty acid after the reaction had proceeded for 5 min, and expressed in munits of specific activity, i.c. in nequivalents of titrateable acidity released per min per mg of protein. Atherosclerosis,
1970, 12: 41-53
44
J. PATELSKI
Malate and lactate dehydrogenases.
DK2 recording
spectrophotometer.
glycine-sodium sodium
hydroxide
buffer
Assays were carried out at 30°C in a Beckman
The reaction
In_-lactate
was measured
(BDH).
by following
Aortic perfusion
aortas
were ligated
sions were carried
L-malate
0.1 ml of extract the increase
(Calbiochem)
was added
in absorption
to start
or 0.1 ml of 1.0 M the reaction
which
at 340 nm (ref. 9).
were perfused
essentially
and the aorta suspensed
as described in a perfusion
out for 1 h at 37°C with Krebs bicarbonate
out the experiment albumin
2.7 ml of 0.1 M
contained
estimation of ,%$&I!composition
ad
The abdominal major branches
cuvettes
(pH 10.0); 0.1 ml of 11.7 mM NAD (Boehringer,
and 0.1 ml of 1.0 M sodium
Germany)
et d.
with Os/5 o/o COs, containing
(Cohn fraction
5, Armour)
beforelo. chamber.
buffer, gassed through-
4 mg/lOO ml defatted
and 0.1 ,uequiv/ml
The Perfu-
bovine
serum
of [ 1-r4C]oleic acid (Amersham,
England). Following the perfusion, the aortas were rinsed with cold 0.9 y. saline and the intima, plus approximately one-third of the inner media peeled off, frozen and disintegrated by freeze pressing. The lipids were then extracted with chloroformmethanol
(2:1, v/v) and aliquots
of the extract
separated
raphy into the major neutral lipids and phospholipids, (Merck) run with light petroleum (b.p. 40-60”C)-diethyl v/v/v).
The separated
lipids were located
by spraying
on thin-layer
chromatog-
using silica gel H plates ether-acetic acid (85:15:1,
plates with a fluorescent
dyerr.
Radioactivity was measured in separated fractions in a Packard series 4000 scintillation counter. The concentrations of lipids were measured by chemical assay; phospholipid cholesterol
by assay of phosphorus, by
the
method
of BABSON
by the method of USHERI~, free and esterified et al.13 and free fatty acids by the method of
MARSH AND WEINSTEIN14.
Macroscopic
and microscopic
examination
of the aortas
The aortas were examined macroscopically for intimal lesions after gross staining with Sudan IV according to the method of HOLMAN et a1.15~16and microscopically after staining sections by a variety of conventional methods. RESULTS
Data on fatty acid composition and concentrations of the substrates used for lecithin contained enzyme activity assays are listed in Table 1. Polyunsaturated 79.3% polyunsaturated fatty acids, mainly linoleic (77.4%) with less than 15% saturated fatty acids. Lecithin from egg yolk contained 24.8% oleic and 55.9 y. saturated fatty acids, mainly palmitic (45.8%). All of the fatty acids in glyceryl trioleate, and 93.7 o/o of the fatty acid in cholesteryl oleate was oleic acid. Not less than 98.5 y. of the total fatty acids of the substrates were present in an esterified form in the hydrosols. The measured concentrations of the substrates in the disperse phase of the hydrosols amounted to 100 y. for polyunsaturated lecithin, approximately 90 y. Atherosclerosis,
1970, 12: 41-53
1
ACID
Lecithin Polyunsaturated lecithin Glyceryl trioleate Cholesteryl oleate
Substrate
FATTY
TABLE
AND
4.2
0.3
1.9
45.8
11.3
1611
76:O
2.6
10.1
18:O
77.4
5.9
93.7
1.4
11.5
24.8
100.0
1812
1.9
1813
OF SUBSTRATES
18x1
CONCENTRATION
Fatty acid composition
COMPOSITION
0.2
2013
100
0.6
24
48
7,002 2,206
0.7 1.1
0
13,300
0
0.9
92
12,215
1.5
190
2.9
2.8
nmolesl ml
%
hydvosol
88
70
y0
esterified (found)
Fatty acid concentration free (found)
others
20~4
2,500
10,000
13,300
2,230
7,050
13,300
12,405
92.m0kl
ml ml 13,300
found
theoretical nmolesl
total
w
G e 1,
;;
5
5 5
5
5
animals
of
No.
OF THE
1.1e
3.1 * 0.7
3.6 & 0.8 3.6 -+ 1.3
3.2 + 0.5
3.4 *
( % wlw)
Extracted proteinb
AORTA
(+) 137 y0 34 f 8.8
42 f 5.2 48 + 8.3
35 * 4.1 100% 41 + 10.8
Pkospholipase A ‘1
18 i
5.7
27 * 8.5
19 * 0.9
Phospholipase AC2
Cholesterol esterasec4
\go; +’ 37 *?1.4 51 * 16.4
30 + 2.4 100 y0 57 f 12.8 + +)
+ +)
19 1O4.4
(t3j;
18 1’6.8 8 + 2.8
(Z5$
24 + 5.8 100 y0 6 & 5.3
(nequivlminlmg)
Lipaseca
361 f
90
419 f 149 422 + 137
381 + 117
Malate dehydrogenasedl
213 f
210 f 271 i
218 &
78
57
84 132
Lactate dehydrogenased2
alIntraperitonea1 injection of 1.0 ml 6 times a week. ~(2,s) Intravenous injections of (2) 0.5 ml and (3) 1 ml 3 times a week. b Extraction from acetone-butanol powder with 50 o/o (v/v) glycerol in water (7.5-15 mg/ml) using a Dacie electric cell suspension mixer, followed by second extraction (7.5-15 mg/0.5 ml) using an Ultra-Turrax homogenizer at 4’C, for 30 min and 10 set respectively. c Reaction mixtures (total volume 1 ml) contained: (1) lecithin 1 mM; (2) polyenephosphatidyl choline 1 mM; (3) glyceryl trioleate 1 mM, reduced glutathioneo .I mM; (4) cholestery loleate 1 mM; reduced glutathione 0.1 mM, sodium taurocholate 4 mM and enzyme extract 0.03-0.06 mg protein/ potassium 0.2-0.4 ml. The pH values were (1,2) 8.0 (3) 8.3 (4) 8.6. The reaction temperature was 30% The titration reagent was 0.002 N hydroxide solution (using pH-Stat, Radiometer). d Reaction mixtures (total volume 3 ml) used were as follows: glycine 0.09 M pH 10, NAD 3.9 * 10-4 M and sodium L-malate 3.3 * 10-s M (1) or sodiumDL-lactate 3.3 * 10-e M (2) and 0.1 ml enzyme extract. The reaction was followed by measuring the increase in absorption at 340 nm at 30°C Beckman DK2 recording spectrophotometer). e Means k standard deviations. The means were compared by Analysis of Variance. Where the values for means were different from control, the statistical significance is indicated by: (+) P < 0.05; (+ +)P < 0.02; (f + +)P < 0.01; (+ + + +) P < 0.001. The percentage changes of significantly altered means are tabulated. Glycerol-ester hydrolase and sterol-ester hydrolase were significantly negatively correlated, Y = -0.96, P < 0.01.
Lipostabilaa
0.9 y0
Lipostabilas NaClas
10 18
18
NaCPl 0.9 %
10
None
Injection
ACTIVITIES
Atherogenic semisynthetic diet containing 20 y0 beef tallow
get (weeks)
Time
DEHYDROGENASE
18
Diet
3
4. P
AND
Control
ESTERASE
0
:
y
Lipostabil
18
114& 11.7 485& 217 (++) 578 f 139 (Jr-k-t) 5
5
5
0
0
5
3
2
0
7
2
1
0
2
3
0
2
0
5.9 f 1.14
4.9 * 1.56d 5.6 -f 1.06 11.4 & 3.60
8.0 & 3.20 15.8 & 6.90
Let
8.1 i 2.85
5.9 f 1.92 7.2 & 1.56
Sph
0.4 * 0.11
1.1 * 1.26 0.5 5 0.38 3.7 + 1.16
4.6 i 0.75 4.1 & 2.08
(ng/mg protein)
LL
free fatty acids
(+)
(-t)
significance
k;+) 1.92
2.4 & 0.91 6.6 + 2.40
free
0.4 & 0.26 4.8 + 1.33 (+++I 3.9 -J= 2.41
ester
cholesterol
For explanation, see Table 2. Grade 0 = no &ions; grade 1 = < 1 %; grade 2 = 1-5 7;; grade 3 = > 5 0h diseased aorta. PE = phosphatidyl ethanolamine. Let = lecithin. Sph = sphingomyelin. LL = lysolecithin. Means f SD. The means were compared by Analysis of Variance. Where the values for means were different from control, the statistical is indicated by: (+) P < 0.05; (+ +) P 6 0.02; (+ + +) P G 0.01.
NaCl 0.9 y0
18
None
0
PE
$hospholi$idsc
total No. of animals
No. of animals at each grade of lesionb
A orta
Aortic atherosclerosis
OF AORTAS
Plasma cholesterol (mgl 100 ml)
COMPOSITION
Injectiona
LIPID
Atherogenic semi-synthetic diet containing 20 y0 beef tallow
zet (wks)
Time
AND
18
OF LESIONS
3
Control
Diet
SEVERITY
TABLE
48
J.
for egg yolk lecithin and cholesteryl amount taken for preparation Specific activities
oleate and 70%
PATELSKI
for glyceryl trioleate
-et ai!.
of the
of the hydrosols.
of the aortic phospholipase
A, lipase, cholesterol
esterase,
malate and lactate dehydrogenases in control and experimental rabbits are presented in Table 2. The mean values of protein extracted from acetone-butanol aortas were not significantly
powders from
different from each other. Animals fed atherogenic
diets and injected with saline showed increased phospholipase A (after 18 weeks) and lipase activities
and decreased cholesterol esterase activities
(both after 10 and 18
weeks) compared with normal. The arterial lipolytic enzyme activities
of animals fed
the atherogenic diet and injected with Lipostabil were not significantly different from normal. No alterations were observed in the activities of malate and lactate dehydrogenases. Atherosclerotic
lesions could be seen macroscopically
in experimental
animals
fed for 18 weeks but not in those fed for 10 weeks. Plasma cholesterol, the extent and severity of atherosclerosis and the lipid composition of aortas is presented in Table 3. Plasma cholesterol
was elevated 4-fold in animals fed the semi-synthetic
diet but
there was no significant difference between those injected with saline or Lipostabil. The lesions in the saline group were well advanced and consisted of collections of lipid-filled cells with pyknotic nuclei, interspersed with fine elastic fibrils, separating the endothelium from the inner elastic lamina. The lipid was in globular form; there were no cholesterol clefts. The inner elastic lamina in all cases was fragmented and has lost its normal refractility.
There was duplication and even triplication of this layer in
some cases. Smooth muscle cells immediately underlying the lesions showed accumulation of lipid in their cytoplasm. Endothelial
cells overlying the lesions were swollen
and presented a rough surface to the circulating blood. Basically, the lesions in animals treated with Lipostabil were similar to those of the saline group, but on a reduced scale. No animals in the group treated with Lipostabil
had severe atherosclerotic
lesions (Grade 3) whilst in contrast, in the groups injected with saline, 2 animals out of 5 showed Grade 3 lesions. There was no significant difference between groups in the concentrations of any of the phospholipid classes. Mean concentrations of esterified and free cholesterol in the aorta were 12 and 2.8 times higher respectively in animals injected with saline and 9.8 and 2.3 times higher in those injected with Lipostabil, compared with normal. Table 4 summarises the results for the incorporation of [1-r%]oleic acid into the aortic phospholipids, free fatty acids, triglycerides and cholesteryl esters. Within each lipid class, a large spread in individual values was observed. Comparison of mean values by Student’s t test revealed only a significant difference in incorporation into cholesterol esters in the controls fed the atherogenic diet. The values of the activities of lipolytic enzymes extracted from liver and serum are shown in Table 5. The atherogenic diet with injection of saline caused a significant increase only in serum phospholipase A activity, compared with normal. The injection of Lipostabil prevented this increase and, furthermore, stimulated the lipase activity of both liver and serum. Cholesterol esterase activity could not be demonAtherosclerosis,
1970, 12: 41-53
4
NaCl 0.9 %
Lipostabil
18
18
5
5
5
No.
LIPIDS
0-f animals
0.79
11.22 + 8.53
5.93 f
7.29 & 4.46~
PL
Incorporation
f- 3.15
9.21 i
6.35
6.14 & 3.62
6.43
FFA
of jl-14C]oleic
acid
(+,P
< 0.05.
a See Table 2. b PL = phospholipids. FFA = free fatty acids. TG = triglycerides. CE = cholesterol esters. c Mean & SD. The means were compared by Student’s t test. Where the means were different from control,
None
Atherogenic semisynthetic diet containing 20 y0 beef tallow
AORTIC
Injectiona
INTO
18
ACID
Control
[1-14’40LEIC
Time on diet (weeks)
OF
Diet
THE INCORPORATION
TABLE
& 6.12
the significance
2.24 & 2.38
5 0.06
tissue)
level is indicated
(+) 304 y0 0.19 & 0.27
100 y0 0.46 & 0.25
0.14
CEb
dry defatted
1.08 + 0.53
4.70
TG
(~r,umoleslmg
by
%
z
5
b
ri .&. 7 E
3
G
2. P
:: F a
2
D
Lipostabil
18
SERUM
5
5
5
No. of animals
BLOOD
2.3
21 & 2.1
20 f
22 & 3.26
16.6 f
6.5
16.9 + 6.1
15.8 & 6.1 3.0
31.4 + 8.7
6.7 f
9.3 * 3.4 100 y0
42 f
44 f 4.0
8.5
39 & 6.4
extracted protein ( % (w/w))
extracted proteinb (% (wlw)) lipasec2 phospholipase A ‘1 (nequiv/min/mg)
Serum
Livev
8.2 f 2.2 (++++) 273 y0 2.6 f 1.6
3.0 & 0.9 100 y0
3.1
(1z7+, + +) 0
26.4 & 3.0
19.2 f
16.8 f 3.6 100% m
phospholipasec4 lipase AC3 (nequiv[minlmg)
8 Intravenous injections of 0.5 ml 3 times a week. b Extraction from acetone-butanol powder with water (20 mg/ml) using a Dacie electric cell suspension mixer at 30°C for 15 min. C Reaction mixtures (total volume 1 ml) contained: (1,3) lecithin 1 mM, (2.4) glycerol trioleate 1 m&I, reduced glutathione 0.1 mM, and liver extract 0.20-0.40 mg protein/O.OS-0.10 ml, or serum extract 0.5-1.0 mg protein/O.OS-0.10 ml. The pH values were (1,3) 8,0, (2) 8.4, and (4) 8.9. The reaction temperature was 30°C. The titraton reagent was 0.002 N potassium hydroxide solution (using pH-Stat Radiometer). * For explanation, see Table 2.
NACl 0.9 %
none
Injections
AND
18
Time on diet (weeks)
OF THE LIVER
Atherogenic semisynthetic diet containing 20 y0 beef tallow
ACTIVITIES
18
5
c0lltr01
Diet
ESTERASE
TABLE
8
MODIFICATION
strated
OF ENZYME
ACTIVITIES
in liver or serum under
No further
experiments
IN EXPERIMENTAL
the conditions
to determine
no significant difference powders in each group.
51
used for the assay of aortic
the optimal
in the amount
ATHEROSCLEROSIS
parameters
of protein
enzymes.
were done. There was
extracted
from acetone-butanol
DISCUSSION
As we have noted beforea, the atherogenic semi-synthetic lipase activity and decreased the cholesterol esterase activity rabbit.
In addition,
pholipase
in this experiment,
A, which was active
there was an increase
against
both
diet increased the of the aorta in the
in the activity
egg yolk lecithin
lecithin. The observation of an increased phospholipase A activity by the improved extraction of enzyme by the double-extraction acetone-butanol
powders.
polyunsaturated
lecithin
The absolute
The relative moreover
lecithin.
Changes in the lipolytic of lesions
and
of the substrate
enzyme
activities
could be demonstrated.
was higher than the rate
due to the different
fatty acid composi-
which influences
the enzyme for the b-position of the lecithins 173. the kind of fatty acid present at the a-positioni7. formation
of egg yolk lecithin
of the egg yolk lecithin
This is probably
tion (see Table 1) and configuration
of hydrolysis
can be explained procedure on the
were the same in all groups.
rate of hydrolysis
for polyunsaturated
rates
of phos-
and polyunsaturated
the specificity
of
The enzyme may also be affected by
of the arterial
wall occurred
There was no change,
before the
however,
in the
aortic malate and lactate dehydrogenases. This observation suggests that although there was a change in enzymes of specific function, there was no change in general metabolic activity. The enzyme activities of serum, and liver, on the other hand, showed a different picture of alteration. The only change was the marked increase in the serum phospholipase
activity.
The present findings, along with the observation between the activities of the arterial lipase and cholesterol in the consideration the arterial
of the mechanism
enzymes
thin, but favours
the accumulation
The cholesterol decreased question
to hyperlipaemia
hydrolysis of whether
of arterial
lipid accumulation.
acts against of cholesterol
esters may accumulate
of a negative correlation esterase, are of importance
retention
The response
of triglyceride
of
and leci-
esters.
in the arterial
wall as a result
of both
and increased synthesis. In fact, it is difficult to answer in cholesterol esterase is primarily or secondarily
a decrease
the in-
volved in this process. It may be that the enzyme is inhibited by some toxic factors, but this has not yet been investigated. It is possible, however, that there is substrate inhibition, which has been demonstrated in vitro19 or, more likely, classical product inhibition of the enzyme. With respect to cholesterol ester synthesis, esterification of cholesterol with fatty acid.+-21 and the enzyme system catalyzing this reaction22 have been demonstrated in the aortic wall. The rate of cholesterol ester formation is clearly influenced by the concentrations of free cholesterol and fatty acids. Cholesterol is synthesised slowly, if at all, by the arterial wall and most is derived from the plasma. Atherosclerosis,
1970, 12: 41-53
et al.
J. PATELSKI
52 On the other hand, fatty acids may be derived result of de nova synthesissepzs, transacylations4 An enhanced aortas of animals
incorporation fed atherogenic
with the concomitant
from the plasma albumin or local lipolysis.
of free fatty
acids into
diet indicates
decrease in the cholesterol
acids will lead to enhanced
accumulation
would be a role of enhanced
lipolysis
cholesterol
a higher turnover esterase,
esters
esters
of the
of these esters. Thus
any excess supply
of cholesterol
in the arterial
and also as a
of fatty
by synthesis.
Such
wall.
On the other hand, an inadequate lipolysis in plasma and liver would favour the maintenance of hyperlipaemia and provide substrates for the arterial enzymes. Prevention
of an increase
in lipase and a decrease
arterial wall could be expected to act favourably lation. An increase in lipolysis in the circulating way by removing Lipostabil
triglyceride
was seen to alter
accumulation
of cholesterol
which
in cholesterol
is the main
substrate
the enzyme
activities
esters.
is in agreement
This
ments,
Lipostabil
did not cause a depression
aortic enzyme
activities.
for the arterial
and, furthermore, with
ADAMS et al.25 on decreased aortic cholesterol accumulation cholesteroldiet and injected with a higher dosage of Lipostabil.
aortic atherosclerosis which we observed basis of decreased hypercholesterolaemia,
of plasma
the
lipase.
to reduce
the
observation
of
cholesterol.
The decrease
in
with Lipostabil could not be explained on the but was more likely due to the changes in
The mechanism
environment
in the
in rabbits fed a high However, in our experi-
of action
remains
to be elucidated.
A better understanding of the mechanism of lipid accumulation wall will depend upon the measurement of relative rates of synthesis of lipids in a physiological
esterase
in reducing cholesterol ester accumublood and liver would act in a similar
and under
the influence
in the arterial and catabolism
of different
agents.
ACKNOWLEDGEMENTS
The authors Council, London, assistance
thank Nattermann for their support.
and Co. of Cologne and the Tobacco They gratefully acknowledge the
Research technical
of Mrs. M. Apps and Mrs. J. King.
REFERENCES PATELSKI, J., 2. WALIGORA AND S. SZULC, Demonstration and some properties of the phosphoRes., 1967, 7: 453. lipase A, lipase and cholesterol esterase from the aortic wall, J. Atherosclev. PATELSKI, J., D. E. BOWYER, A. N. HOWARD AND G. A. GRESHAM, Changes in phospholipase A, lipase and cholesterol esterase activity in the aorta in experimental atherosclerosis in the rabbit and rat, J. Atheroscler. Res., 1968, 8: 221. BOWYER, D. E., W. M. F. LEAT, A. N. HOWARD AND G. A. GRESHAM, The determination of the fatty acid composition of serum lipids separated by thin-layer chromatography; and a comparison with column chromatography, Biochim. biophys. Acta (Am-t.), 1963, 70: 423. ALBRINK, M. J., The microtitration of total fatty acids of serum with notes on the estimation of triglycerides, J. Lipid Res., 1959, 1: 53. DOLE, V. P., A relation between non-esterified fatty acids in plasma and the metabolism of glucose, J. din. Invest., 1955, 35: 150. HOWARD, A. N., G. A. GRESHAM, D. JONES AND I. W. JENNINGS, The prevention of rabbit atherosclerosis by soya bean meal, J. Atheroscler. Res., 1965, 5: 330.
Atherosclerosis,
1970, 12: 41-53
MODIFICATION
OF ENZYME
ACTIVITIES
IN EXPERIMENTAL
ATHEROSCLEROSIS
53
7 MORTON, R. K., Method of extraction of enzymes from animal tissues. In: S. P. COLOWICK AND N. 0. KAPLAN (Eds.), Methods in Enzymology, Vol. 7, Academic Press, New York, 1955, p. 25. * LECCETT BAILEY, J., Techniques in Protein Chemislvy, Elsevier, Amsterdam, 1962, p. 293. 9 NEILANDS, J. B., Lactic dehydrogenase of heart muscle. In: S. P. COLOWICK AND N. 0. KAPLAN (Eds.) Methods in Enzymology, Vol. 1, Academic Press, New York, 1955, p. 449. 10 BOWYER, D. E., A. N. HOWARD, G. A. GRESHAM, D. BATES AND B. V. PALMER, Aortic perfusion in experimental animals. A system for the study of lipid synthesis and accumulation, Biochem. Pharmacol., 1968, 4: 235. 11 JONES, D., D. E. BOWYER, G. A. GRESHA~~AND A. N. HOWARD, An improved spray reagent for detecting lipids on thin-layer chromatograms, J. Chromatog., 1966, 23: 172. 12 USHER, D. A., The estimation of phosphorus on paper chromatograms, J. Chromatog., 1963, 12: 262. 13 BABSON, A. L., P. 0. SHAPIRO AND 0. E. PHILLIPS, A new assay for cholesterol and cholesterol
ester in serum which is not affected by bilirubin, Cl&. chim. Acta, 1962, 7: 800. 14 MARSH, J. B. AND D. B. WEINSTEIN, Simple charring method for determination of lipids, ,I. Lipid Res., 1966, 7: 574. 15 HOLMAN, R. L., H. C. MCGILL, J. P. STRONG AND J. C. GEER, Macroscopic staining of aortas with Sudan, Lab. Invest., 1958, 7: 4. 16 HOWARD, A. N., G. A. GRESHAM, I. W. JENNINGS AND D. JONES, The effect of drugs on hypercholesterolaemia and atherosclerosis induced by semi-synthetic low cholesterol diets, Progr. biochem. Pharmacol., 1967, 2: 117. 17 MOORE, J. H. AND D. E. WILLIAMS, Some observations on the specificitv of phospholipasc A, Biochim. biophys. Acta (Amst.), 1964, 84: 41. 18 DE HAAS, G. H., F. J. M. DAEMEN AND L. L. M. VAN DEENEN, Positional specificity of phosphatide acyl hydrolase (phospholipase A), Nature (Lond.), 1962, 196: 68. 19 PATELSKI, J., Esteraza Cholesterolowa Tetnicv Gtownej (Cholesterol esterase of the aorta), Panstwowy Zaktad Wydawnictw Lekarskich,’ Warszawa, 1964. 20 LOFLAND, H. B., JR., D. M. MOURY, C. W. HOFFMAN AND T. B. CLARKSON, Lipid metabolism in pigeon aorta during atherogenesis, J. Lipid Res., 1965, 6: 112. 21 BOWYER, D. E., A. N. HOWARD AND G. A. GRESHAM, Lipid synthesis in perfused normal and atherosclerotic rabbit aortas, Biochem. J,, 1967, 103: 54 P. 22 PNIE~SKA, B., Enzymatyczna estryfikacja cholesterolu w tetnicy gtownej (Enzymatic esterification of cholesterol in the aorta), To be published. 23 WHEREAT, A. F., Fatty acid synthetis in cell-free system from rabbit aorta, J. Lipid Res., 1966, 7: 671. 24 ABDULLA, Y. H., C. C. ORTON AND C. W. M. ADAMS, Cholesterol esterification bv transacylation in human and experimental atheromatous lesions, J. Atheroscler. Res., 1968, 8: 967. 25 ADAMS, C. W. M.. Y. H. ABDULLA, 0. B. BAYLISS AND R. S. MORGAN, Modification of aortic atheroma and fatty liver in cholesterol-fed rabbits by intravenous injection of saturated and polyunsaturated lecithins, J. Path. Back, 1967, 94: 77.
Atherosclerosis,
1970, 12: 41-53